Information Library
Results for: Oncology - Phase I/IIa
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Harish Dave Discusses ASH 2011
Hear from the Experts — December 8, 2011
Harish Dave discusses the American Society of Hematology annual meeting. -
The Molecular Biomarker Revolution in Non-Small Cell Lung Cancer
White Paper — June 23, 2011
In this new white paper Quintiles’ experts Christopher Ung, Jason Hill, Carrie Lee and Harish Dave review some of the most promising molecular pathways and targeted approaches for NSCLC, the critical role of diagnostics, and strategies to detect and address the emergence of resistance. -
Genomics Fact Sheet
Brochure — June 17, 2011
Approximately 20% of today’s U.S. Clinical Trials use genomic technology. Find out about Quintiles’ offerings in this area. -
CardioCheck
White Paper — May 10, 2011
Quintiles' CardioCheck program is designed to provide rapid insight into potential cardiotoxic influences of pharmaceutical compounds. -
Quintiles Speeds Early-Phase Decision Making with New Unit in Hyderabad, India
Press Release — January 24, 2011 – Quintiles officially opened its new Phase I research facility in Hyderabad, India at Apollo Health City.
-
Exclusive Report From Scientific American
Hear from the Experts — November 9, 2010
In-depth insights on every angle of the changing health landscape - brought to you by Quintiles Get the report today. -
From Biomarkers to Diagnostics - The Road to Success
White Paper — October 18, 2010
In the second installment of a two-part series, Eric Groves, Jason Hill and Christopher Ung walk through the challenges associated with drug-diagnostic co-development, addressing potential pitfalls and areas of opportunity. -
Management of Tissue Specimens for Oncology Drug Development in China
Presentation — October 1, 2010
Download Patty James of Quintiles recent presentation Management of Tissue Specimens for Oncology Drug Development in China from the Clinical Development of Cancer Drugs in China -
Outsourcing Oncology Molecular Biomarkers - Considerations for Emerging Countries
Presentation — October 1, 2010
Download Christopher Ung of Quintiles recent presentation, Outsourcing Oncology Molecular Biomarkers - Considerations for Emerging Countries from the Clinical Development of Cancer Drugs in China -
New Global Trends in Novel Oncology Drug Development
Presentation — October 1, 2010
Download Harish Dave, MD, MBA of Quintiles recent presentation New Global Trends in Novel Oncology Drug Development from the Clinical Development of Cancer Drugs
